AU2003295618A1 - Water-soluble mesoporphyrin compounds and methods of preparation - Google Patents

Water-soluble mesoporphyrin compounds and methods of preparation Download PDF

Info

Publication number
AU2003295618A1
AU2003295618A1 AU2003295618A AU2003295618A AU2003295618A1 AU 2003295618 A1 AU2003295618 A1 AU 2003295618A1 AU 2003295618 A AU2003295618 A AU 2003295618A AU 2003295618 A AU2003295618 A AU 2003295618A AU 2003295618 A1 AU2003295618 A1 AU 2003295618A1
Authority
AU
Australia
Prior art keywords
mesoporphyrin
tin
compound
amino acid
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003295618A
Other languages
English (en)
Inventor
George S. Drummond
Benjamin Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infacare Pharmaceutical Corp
Original Assignee
Infacare Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infacare Pharmaceutical Corp filed Critical Infacare Pharmaceutical Corp
Publication of AU2003295618A1 publication Critical patent/AU2003295618A1/en
Assigned to INFACARE PHARMACEUTICAL CORPORATION reassignment INFACARE PHARMACEUTICAL CORPORATION Request for Assignment Assignors: WELLSPRING PHARMACEUTICAL CORPORATION
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003295618A 2002-11-20 2003-11-18 Water-soluble mesoporphyrin compounds and methods of preparation Abandoned AU2003295618A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42785102P 2002-11-20 2002-11-20
US60/427,851 2002-11-20
PCT/US2003/036885 WO2004045546A2 (en) 2002-11-20 2003-11-18 Water-soluble mesoporphyrin compounds and methods of preparation

Publications (1)

Publication Number Publication Date
AU2003295618A1 true AU2003295618A1 (en) 2004-06-15

Family

ID=32326603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003295618A Abandoned AU2003295618A1 (en) 2002-11-20 2003-11-18 Water-soluble mesoporphyrin compounds and methods of preparation

Country Status (6)

Country Link
US (1) US20040097481A1 (https=)
EP (1) EP1567165A4 (https=)
JP (1) JP2006506440A (https=)
AU (1) AU2003295618A1 (https=)
CA (1) CA2506081C (https=)
WO (1) WO2004045546A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
AU2003237349B2 (en) * 2002-06-04 2010-06-03 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
EP1865777A4 (en) * 2005-04-01 2008-07-16 Infacare Pharmaceutical Corp STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
US20080113955A1 (en) * 2006-10-04 2008-05-15 Benjamin Levinson Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
AU2012202684B2 (en) * 2006-10-04 2014-04-10 Mallinckrodt Hospital Products IP Limited High-purity large-scale preparation of stannsoporfin
US7960371B2 (en) * 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
CN110522905A (zh) * 2008-01-21 2019-12-03 德莫迪斯公司 丝氨酸蛋白酶抑制剂在治疗皮肤病中的用途
PL2691398T3 (pl) 2011-03-30 2017-07-31 Infacare Pharmaceutical Corporation Sposoby syntezy mezoporfiryn metali

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US225264A (en) * 1880-03-09 Alpbed akeb
US4708964A (en) * 1984-02-09 1987-11-24 Chemex Pharmaceuticals Lipoxygenase inhibitors
US4692440A (en) * 1985-03-25 1987-09-08 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5912341A (en) * 1995-03-14 1999-06-15 Hoffman/Barrett, L.L.C. Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
WO1997005152A1 (en) * 1995-08-02 1997-02-13 Warner-Lambert Company Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix
JP2003526668A (ja) * 2000-03-10 2003-09-09 ザ ロックフェラー ユニバーシティー 心臓血管損傷の調節
CA2448570A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
AU2003237349B2 (en) * 2002-06-04 2010-06-03 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds

Also Published As

Publication number Publication date
US20040097481A1 (en) 2004-05-20
EP1567165A2 (en) 2005-08-31
JP2006506440A (ja) 2006-02-23
CA2506081C (en) 2009-08-04
EP1567165A4 (en) 2006-10-18
WO2004045546A3 (en) 2004-07-08
WO2004045546A2 (en) 2004-06-03
CA2506081A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
EP1654263B1 (en) Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
US9061968B2 (en) Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
CA2506081C (en) Water-soluble mesoporphyrin compounds and methods of preparation
JP6195367B2 (ja) 組成物
IE51342B1 (en) Substituted pyrazinyl-1,2,4-oxadiazol-5-ones,a process for preparing same and a pharmaceutical composition containing same
CA2433181C (en) Amlodipine hemifumarate
JPH11513989A (ja) 成長ホルモン分泌促進薬の湿式造粒製剤
EP3115356A1 (en) Polymorphs of bromfenac sodium and methods for preparing bromfenec sodium ploymorphs
ZA200708892B (en) Stannsoporfin compositions and administration
CN1950346A (zh) N－去甲基氯氮平的晶形
US7786168B2 (en) Phenolic acid salts of gabapentin in solid dosage forms and methods of use
WO1997005152A1 (en) Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix
JPH0526782B2 (https=)
JPH0780901B2 (ja) Ｌ−５−ヒドロキシトリプトファンの新規なジペプチド類およびそれらを製造する方法並びにそれらジペプチド類を含む薬剤
EP1880992A1 (en) Stable modifications of tegaserod hydrogen maleate
JP2008509914A5 (https=)
JPS63264420A (ja) 新規なチアミンコバルチクロロフイリン錯化合物含有抗潰瘍剤
HK40074647A (en) Composition containing legoamodipine besylate hydrate and preparation method therefor
AU2001100435A4 (en) Amlodipine fumarate
FR2896801A1 (fr) Nouveaux composes dipeptidiques, les compositions pharmaceutiques en renfermant ainsi que leur procede d'obtention
JP2000503683A (ja) 新規ビフェニルジカルボン酸誘導体およびそれらの調製方法
HK1055968B (en) Amlodipine fumarate
HK1034183B (en) Galenic formulations of meloxicam for oral administration
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration
JPH036152B2 (https=)

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: INFACARE PHARMACEUTICAL CORPORATION

Free format text: FORMER APPLICANT(S): WELLSPRING PHARMACEUTICAL CORPORATION

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted